Experiment 837875

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationKAVANAGH,JJ: GERSHENSON,DM: COPELAND,LJ: WHARTON,JT: RUTLEDGE,FN: KRAKOFF,IH:. (1984). INTERMITTENT IV HOMOHARRINGTONINE FOR THE TREATMENT OF REFRACTORY EPITHELIAL CARCINOMA OF THE OVARY: A PHASE II TRIAL.. 68(12)
Amount utilized
Compound isolated
Disease17 PATIENTS WITH REFRACTORY EPITHELIAL CA OF THE OVARY SHOWED NO SIGNIFICANT RESPONSE. SIDE EFFECTS INCLUDED MILD NAUSEA, VOMITING AND NEUTROPENIC-RELATED INFECTIONS. THIS WAS A PHASE II STUDY.
Dose amount3.0 MG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitSQ M
Dose expressionDOSE